Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 209

1.

Cognition, psychosis risk and metabolic measures in two adolescent birth cohorts - CORRIGENDUM.

Ramsay H, Barnett JH, Murray GK, Miettunen J, Mäki P, Järvelin MR, Smith GD, Ala-Korpela M, Veijola J.

Psychol Med. 2018 Aug 30:1. doi: 10.1017/S0033291718002192. [Epub ahead of print] No abstract available.

PMID:
30157972
2.

A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response.

Macare C, Ducci F, Zhang Y, Ruggeri B, Jia T, Kaakinen M, Kalsi G, Charoen P, Casoni F, Peters J, Bromberg U, Hill M, Buxton J, Blakemore A, Veijola J, Büchel C, Banaschewski T, Bokde ALW, Conrod P, Flor H, Frouin V, Gallinat J, Garavan H, Gowland PA, Heinz A, Ittermann B, Lathrop M, Martinot JL, Paus T, Desrivières S, Munafò M, Järvelin MR, Schumann G; IMAGEN Consortium.

Eur Neuropsychopharmacol. 2018 Aug 10. pii: S0924-977X(18)30284-0. doi: 10.1016/j.euroneuro.2018.07.101. [Epub ahead of print]

PMID:
30104163
3.

Cognition, psychosis risk and metabolic measures in two adolescent birth cohorts.

Ramsay H, Barnett JH, Murray GK, Miettunen J, Mäki P, Järvelin MR, Smith GD, Ala-Korpela M, Veijola J.

Psychol Med. 2018 Jul 24:1-15. doi: 10.1017/S0033291718001794. [Epub ahead of print]

PMID:
30039772
4.

Age at first birth in women is genetically associated with increased risk of schizophrenia.

Ni G, Gratten J, Wray NR, Lee SH; Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Sci Rep. 2018 Jul 5;8(1):10168. doi: 10.1038/s41598-018-28160-z.

5.

Profiles of Contextual Risk at Birth and Adolescent Substance Use.

Parra GR, Smith GL, Mason WA, Savolainen J, Chmelka MB, Miettunen J, Järvelin MR, Moilanen I, Veijola J.

J Child Fam Stud. 2018 Mar;27(3):717-724. doi: 10.1007/s10826-017-0935-x. Epub 2017 Nov 17.

PMID:
29861618
6.

Habitual coffee consumption and cognitive function: a Mendelian randomization meta-analysis in up to 415,530 participants.

Zhou A, Taylor AE, Karhunen V, Zhan Y, Rovio SP, Lahti J, Sjögren P, Byberg L, Lyall DM, Auvinen J, Lehtimäki T, Kähönen M, Hutri-Kähönen N, Perälä MM, Michaëlsson K, Mahajan A, Lind L, Power C, Eriksson JG, Raitakari OT, Hägg S, Pedersen NL, Veijola J, Järvelin MR, Munafò MR, Ingelsson E, Llewellyn DJ, Hyppönen E.

Sci Rep. 2018 May 14;8(1):7526. doi: 10.1038/s41598-018-25919-2.

7.

Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood.

Ni G, Moser G; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Wray NR, Lee SH.

Am J Hum Genet. 2018 Jun 7;102(6):1185-1194. doi: 10.1016/j.ajhg.2018.03.021. Epub 2018 May 10.

8.

Interaction between compound genetic risk for schizophrenia and high birth weight contributes to social anhedonia and schizophrenia in women.

Liuhanen J, Suvisaari J, Kajantie E, Miettunen J, Sarin AP, Järvelin MR, Lönnqvist J, Veijola J, Paunio T.

Psychiatry Res. 2018 Jan;259:148-153. doi: 10.1016/j.psychres.2017.10.020. Epub 2017 Oct 9.

PMID:
29049906
9.

Vitamin D and cognitive function: A Mendelian randomisation study.

Maddock J, Zhou A, Cavadino A, Kuźma E, Bao Y, Smart MC, Saum KU, Schöttker B, Engmann J, Kjærgaard M, Karhunen V, Zhan Y, Lehtimäki T, Rovio SP, Byberg L, Lahti J, Marques-Vidal P, Sen A, Perna L, Schirmer H, Singh-Manoux A, Auvinen J, Hutri-Kähönen N, Kähönen M, Kilander L, Räikkönen K, Melhus H, Ingelsson E, Guessous I, Petrovic KE, Schmidt H, Schmidt R, Vollenweider P, Lind L, Eriksson JG, Michaëlsson K, Raitakari OT, Hägg S, Pedersen NL, Herzig KH, Järvelin MR, Veijola J, Kivimaki M, Jorde R, Brenner H, Kumari M, Power C, Llewellyn DJ, Hyppönen E.

Sci Rep. 2017 Oct 16;7(1):13230. doi: 10.1038/s41598-017-13189-3.

10.

Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.

Huhtaniska S, Jääskeläinen E, Heikka T, Moilanen JS, Lehtiniemi H, Tohka J, Manjón JV, Coupé P, Björnholm L, Koponen H, Veijola J, Isohanni M, Kiviniemi V, Murray GK, Miettunen J.

Psychiatry Res Neuroimaging. 2017 Aug 30;266:73-82. doi: 10.1016/j.pscychresns.2017.05.009. Epub 2017 May 20.

PMID:
28618327
11.

Early adversity and brain response to faces in young adulthood.

Lieslehto J, Kiviniemi V, Mäki P, Koivukangas J, Nordström T, Miettunen J, Barnett JH, Jones PB, Murray GK, Moilanen I; IMAGEN, Paus T, Veijola J.

Hum Brain Mapp. 2017 Sep;38(9):4470-4478. doi: 10.1002/hbm.23674. Epub 2017 Jun 14.

PMID:
28612935
12.

Cytokine data obtained from synovial stromal cells of patients with rheumatoid arthritis or osteoarthritis.

Huhtakangas JA, Veijola J, Turunen S, Karjalainen A, Valkealahti M, Nousiainen T, Yli-Luukko S, Vuolteenaho O, Lehenkari P.

Data Brief. 2017 Apr 29;12:593-602. doi: 10.1016/j.dib.2017.04.041. eCollection 2017 Jun.

13.

Genome-Wide Association Study of Psychosis Proneness in the Finnish Population.

Ortega-Alonso A, Ekelund J, Sarin AP, Miettunen J, Veijola J, Järvelin MR, Hennah W.

Schizophr Bull. 2017 Oct 21;43(6):1304-1314. doi: 10.1093/schbul/sbx006.

PMID:
28525603
14.

Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.

Huhtaniska S, Jääskeläinen E, Hirvonen N, Remes J, Murray GK, Veijola J, Isohanni M, Miettunen J.

Hum Psychopharmacol. 2017 Mar;32(2). doi: 10.1002/hup.2574. Review.

PMID:
28370309
15.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

16.

Structural properties of the human corpus callosum: Multimodal assessment and sex differences.

Björnholm L, Nikkinen J, Kiviniemi V, Nordström T, Niemelä S, Drakesmith M, Evans JC, Pike GB, Veijola J, Paus T.

Neuroimage. 2017 May 15;152:108-118. doi: 10.1016/j.neuroimage.2017.02.056. Epub 2017 Feb 22.

PMID:
28254453
17.

1,25(OH)2D3 and calcipotriol, its hypocalcemic analog, exert a long-lasting anti-inflammatory and anti-proliferative effect in synoviocytes cultured from patients with rheumatoid arthritis and osteoarthritis.

Huhtakangas JA, Veijola J, Turunen S, Karjalainen A, Valkealahti M, Nousiainen T, Yli-Luukko S, Vuolteenaho O, Lehenkari P.

J Steroid Biochem Mol Biol. 2017 Oct;173:13-22. doi: 10.1016/j.jsbmb.2017.01.017. Epub 2017 Feb 3.

PMID:
28167299
18.

The Effect of Gray Matter ICA and Coefficient of Variation Mapping of BOLD Data on the Detection of Functional Connectivity Changes in Alzheimer's Disease and bvFTD.

Tuovinen T, Rytty R, Moilanen V, Abou Elseoud A, Veijola J, Remes AM, Kiviniemi VJ.

Front Hum Neurosci. 2017 Jan 9;10:680. doi: 10.3389/fnhum.2016.00680. eCollection 2016.

19.

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.

Sundquist E, Kauppila JH, Veijola J, Mroueh R, Lehenkari P, Laitinen S, Risteli J, Soini Y, Kosma VM, Sawazaki-Calone I, Macedo CC, Bloigu R, Coletta RD, Salo T.

Br J Cancer. 2017 Feb 28;116(5):640-648. doi: 10.1038/bjc.2016.455. Epub 2017 Jan 17.

20.

Association between family history of psychiatric disorders and long-term outcome in schizophrenia - The Northern Finland Birth Cohort 1966 study.

Käkelä J, Marttila R, Keskinen E, Veijola J, Isohanni M, Koivumaa-Honkanen H, Haapea M, Jääskeläinen E, Miettunen J.

Psychiatry Res. 2017 Mar;249:16-22. doi: 10.1016/j.psychres.2016.12.040. Epub 2016 Dec 27.

PMID:
28063393

Supplemental Content

Loading ...
Support Center